C. Lynde

发表

Understanding and Assessing Potential Serious Adverse Events: A Practical Approach to Understanding the Benefits and Harm of Psoriasis Treatments

W. Gulliver, K. Papp, Jerry Tan, 2013, Journal of cutaneous medicine and surgery.

Biological therapies in the systemic management of psoriasis: International Consensus Conference

J. Saurat, S. Chimenti, J. Ortonne, 2004, The British journal of dermatology.

Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document

W. Gulliver, M. Gooderham, S. Kalia, 2017, Journal of cutaneous medicine and surgery.

Integrating Biologic Agents into Management of Moderate-to-Severe Psoriasis: A Consensus of the Canadian Psoriasis Expert Panel

K. Papp, R. Bissonnette, Y. Poulin, 2004, Journal of cutaneous medicine and surgery.

Shifting the focus – the primary role of IL‐23 in psoriasis and other inflammatory disorders

M. Gooderham, K. Papp, C. Lynde, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate to severe atopic dermatitis: results from the JADE REGIMEN phase 3 trial.

M. Lebwohl, J. Silverberg, T. Bieber, 2021, Journal of the American Academy of Dermatology.

Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial

M. Lebwohl, J. Silverberg, T. Bieber, 2021 .

Clinical Insights About Topical Treatment of Mild-to-Moderate Pediatric and Adult Atopic Dermatitis

L. Guenther, C. Lynde, J. Bergman, 2019, Journal of cutaneous medicine and surgery.

Patient impact and economic burden of mild-to-moderate atopic dermatitis

R. Gerber, J. Cappelleri, C. Lynde, 2018, Current medical research and opinion.

Use of pimecrolimus cream 1% (Elidel®) in the treatment of atopic dermatitis in infants and children: the effects of ethnic origin and baseline disease severity on treatment outcome

C. Lynde, R. Langley, R. Kaufmann, 2005, International journal of dermatology.

International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis.

A. Gottlieb, I. Olivieri, D. Gladman, 2009, Arthritis and rheumatism.

Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada ‐ a multicenter survey of 2001 patients

R. Summerbell, C. Lynde, Aditya K. Gupta, 1997, International journal of dermatology.

Prevalence and Epidemiology of Onychomycosis

Y. Poulin, C. Lynde, R. Vender, 2006 .

A higher prevalence of onychomycosis in psoriatics compared with non‐psoriatics: a multicentre study

B. Elewski, C. R. Daniel, R. Summerbell, 1997, The British journal of dermatology.

The COVID-19 pandemic and its skin effects

Anthony R. Zara, A. Zara, C. Lynde, 2021, Canadian Family Physician Le Médecin de famille canadien.

Immune response to pneumococcal polysaccharide vaccine in adults with chronic plaque psoriasis treated with alefacept.

C. Lynde, J. Krell, N. Korman, 2011, Journal of the American Academy of Dermatology.

Alefacept: clinical use in treating psoriasis

C. Lynde, P. Dakin, 2006 .

Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches

K. Papp, Y. Poulin, N. Shear, 2005, Journal of cutaneous medicine and surgery.

Incorporating Biologics into the Treatment of Psoriasis

H. Lui, W. Gulliver, Y. Poulin, 2004, Journal of cutaneous medicine and surgery.

The Use of Alefacept in the Treatment of Psoriasis

W. Gulliver, Y. Poulin, L. Guenther, 2004, Journal of cutaneous medicine and surgery.

Incorporating Biologics into the Treatment of Psoriasis

H. Lui, W. Gulliver, Y. Poulin, 2004, Journal of cutaneous medicine and surgery.

The Use of Alefacept in the Treatment of Psoriasis

W. Gulliver, Y. Poulin, L. Guenther, 2004, Journal of Cutaneous Medicine and Surgery.

Moisturizers: what they are and how they work.

C. Lynde, 2001, Skin therapy letter.

The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials

W. Gulliver, C. Lynde, P. Fleming, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review

W. Gulliver, J. Pope, B. Haraoui, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Psoriasis and adverse pregnancy outcomes: a systematic review of observational studies

W. Gulliver, C. Lynde, P. Fleming, 2016, The British journal of dermatology.

Psoriasis and Smoking

W. Gulliver, J. Pope, B. Haraoui, 2016, Journal of cutaneous medicine and surgery.

The Relationship of Obesity With the Severity of Psoriasis

W. Gulliver, C. Lynde, J. Kraft, 2015, Journal of cutaneous medicine and surgery.

Canadian Clinical Practice Guidelines for Rosacea

C. Cochrane, A. Baibergenova, Y. Poulin, 2016, Journal of cutaneous medicine and surgery.

Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel

S. Walmsley, M. Gooderham, K. Papp, 2022, Dermatology and Therapy.

Dr. Roubille, et al reply

W. Gulliver, J. Pope, B. Haraoui, 2016, The Journal of Rheumatology.

Multiple melanomas occurring in a patient with xeroderma pigmentosum.

D. McLean, C. Lynde, W. D. Stewart, 1984, Journal of the American Academy of Dermatology.

Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE‐CSU

F. Bérard, A. Knulst, C. Lynde, 2018, Allergy.

The burden of chronic spontaneous urticaria is substantial: Real‐world evidence from ASSURE‐CSU

F. Bérard, A. Knulst, A. Giménez-Arnau, 2017, Allergy.

Biologic Treatment in Elderly Patients With Psoriasis: A Systematic Review

C. Lynde, P. Fleming, V. Sandhu, 2020, Journal of cutaneous medicine and surgery.

TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled Study.

J. Tardif, M. Guertin, R. Bissonnette, 2017, The Journal of investigative dermatology.

Understanding Genital Warts: Epidemiology, Pathogenesis, and Burden of Disease of Human Papillomavirus

C. Lynde, R. Vender, M. Bourcier, 2013, Journal of cutaneous medicine and surgery.

Management of acne: Canadian clinical practice guideline

A. Baibergenova, Y. Poulin, Jerry Tan, 2016, Canadian Medical Association Journal.

Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.

C. Lynde, N. Konnikov, A. Gupta, 2001, Journal of the American Academy of Dermatology.

Moisturizers and Ceramide-containing Moisturizers May Offer Concomitant Therapy with Benefits.

W. Gulliver, C. Lynde, S. Skotnicki, 2014, The Journal of clinical and aesthetic dermatology.

Efficacy and safety of oral alitretinoin (9‐cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double‐blind, placebo‐controlled, multicentre trial

P. Elsner, Å. Svensson, M. Lahfa, 2008, The British journal of dermatology.

Use of Biologic Therapeutics in Difficult-to-Treat Psoriasis

C. Lynde, 2009, Journal of cutaneous medicine and surgery.

Etanercept Improves Quality of Life Outcomes and Treatment Satisfaction in Patients with Moderate to Severe Plaque Psoriasis in Clinical Practice

C. Lynde, R. Vender, M. Poulin-Costello, 2012, Journal of cutaneous medicine and surgery.

The Burden of Psoriasis in Canada: Insights from the pSoriasis Knowledge IN Canada (SKIN) Survey

C. Jackson, Y. Poulin, L. Guenther, 2009, Journal of cutaneous medicine and surgery.

Practical Considerations for the Initiation and Maintenance of Etanercept in the Treatment of Psoriasis

L. Guenther, C. Lynde, V. Ho, 2007 .

Real‐world, long‐term treatment patterns of commonly used biologics in Canadian patients with moderate‐to‐severe chronic plaque psoriasis

M. Gooderham, K. Papp, C. Lynde, 2021, The Journal of dermatology.

Tofacitinib in the Treatment of Rheumatoid Arthritis and Chronic Plaque Psoriasis.

M. Cernea, C. Lynde, A. Gupta, 2017, Skin therapy letter.

Effect of Ixekizumab Treatment on Work Productivity for Patients With Moderate-to-Severe Plaque Psoriasis: Analysis of Results From 3 Randomized Phase 3 Clinical Trials.

A. Armstrong, E. Edson-Heredia, K. Gordon, 2016, JAMA dermatology.

Comparison of Management Guidelines for Moderate-to-Severe Plaque Psoriasis: A Review of Phototherapy, Systemic Therapies, and Biologic Agents

W. Gulliver, N. Shear, C. Lynde, 2018, Journal of cutaneous medicine and surgery.

Interleukin 17A: toward a new understanding of psoriasis pathogenesis.

Y. Poulin, C. Lynde, R. Vender, 2014, Journal of the American Academy of Dermatology.

Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study.

M. Gooderham, K. Papp, C. Lynde, 2017, Journal of drugs in dermatology : JDD.

Think beyond the Skin

W. Gulliver, Y. Poulin, C. Lynde, 2015, Journal of cutaneous medicine and surgery.

Canadian Consensus Guidelines on Human Papillomavirus

D. Provencher, J. Frappier, V. Senikas, 2007 .

Gaps and recommendations for clinical management of truncal acne from the Personalising Acne: Consensus of Experts panel

B. Dréno, S. Beissert, Jerry Tan, 2021, JAAD international.

Identifying gaps and providing recommendations to address shortcomings in the investigation of acne sequelae by the Personalising Acne: Consensus of Experts panel

B. Dréno, S. Beissert, Jerry Tan, 2021, JAAD international.

Meta‐Analysis of Tumor Necrosis Factor Inhibitors and Glucocorticoids on Bone Density in Rheumatoid Arthritis and Ankylosing Spondylitis Trials

W. Gulliver, J. Pope, B. Haraoui, 2015, Arthritis care & research.

Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

K. Peris, M. Cork, M. Worm, 2020, The British journal of dermatology.

Efficacy and safety of adalimumab when added to inadequate therapy for the treatment of psoriasis: results of PRIDE, an open‐label, multicentre, phase IIIb study

K. Papp, C. Lynde, B. Guérette, 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

Canadian Practical Guide for the Treatment and Management of Atopic Dermatitis

N. Shear, C. Lynde, R. Langley, 2005, Journal of cutaneous medicine and surgery.

Multidisciplinary Real-World Experience With Bilastine, a Second Generation Antihistamine

J. Rao, J. Hébert, L. Guenther, 2020, Journal of drugs in dermatology : JDD.

A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept

R. Bissonnette, Y. Poulin, L. Guenther, 2012, The Journal of dermatological treatment.

Adult-Onset Atopic Dermatitis: Presentations and Progress

A. Drucker, C. Lynde, P. Fleming, 2020, Journal of cutaneous medicine and surgery.

Insights and advances in chronic urticaria: a Canadian perspective

William H. Yang, F. Simons, P. Vadas, 2015, Allergy, Asthma & Clinical Immunology.

Pimecrolimus cream 1% in the treatment of pediatric atopic dermatitis

C. Lynde, 2007 .

Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis

C. Leonardi, C. Ryan, B. Hendrickson, 2018, American Journal of Clinical Dermatology.

A Refresher on Herpes Zoster, Current Status on Vaccination, and the Role of the Dermatologist

L. Guenther, C. Lynde, 2011, Journal of cutaneous medicine and surgery.

Canadian Guidelines for the Management of Plaque Psoriasis: Overview

J. Ashkenas, W. Gulliver, K. Papp, 2011, Journal of cutaneous medicine and surgery.

Impact of Desloratadine on Symptoms and Quality of Life in Subjects with Chronic Idiopathic Urticaria: A Multicenter, Practice-based Study

C. Lynde, Harold Kim, 2008, Archives of drug information.

The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody.

H. Lui, J. Shapiro, W. Gulliver, 2001, Journal of the American Academy of Dermatology.

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section I: Pathophysiology of Atopic Dermatitis and Implications for Systemic Therapy

M. Gooderham, C. Lynde, M. Kirchhof, 2018, Journal of cutaneous medicine and surgery.

Clinical Goals and Barriers to Effective Psoriasis Care

B. Strober, A. Gottlieb, A. Kimball, 2018, Dermatology and Therapy.

Response to Hjuler et al.

J. Tardif, M. Guertin, R. Bissonnette, 2017, The Journal of investigative dermatology.

Long‐term adalimumab efficacy in patients with moderate‐to‐severe hidradenitis suppurativa/acne inversa: 3‐year results of a phase 3 open‐label extension study

C. Zouboulis, G. Jemec, P. Foley, 2019, Journal of the American Academy of Dermatology.

Patient‐reported outcomes in moderate‐to‐severe plaque psoriasis with scalp involvement: results from a randomized, double‐blind, placebo‐controlled study of etanercept

S. Tyring, C. Lynde, G. Kricorian, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

Moderate to severe plaque psoriasis with scalp involvement: a randomized, double-blind, placebo-controlled study of etanercept.

S. Tyring, C. Lynde, G. Kricorian, 2012, Journal of the American Academy of Dermatology.

Topical treatment of psoriasis: questionnaire results on topical therapy as long-term continuous treatment and use on specific body sites

J. M. van der Walt, L. Iversen, P. C. van de Kerkhof, 2020, The Journal of dermatological treatment.

Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi Study

W. Gulliver, M. Gooderham, C. Fahim, 2019, Journal of cutaneous medicine and surgery.

Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.

A. Fleischer, Z. Draelos, M. Steinhoff, 2014, Journal of drugs in dermatology : JDD.

An Open Letter to Health Canada

W. Gulliver, M. Wiseman, M. Gooderham, 2017, Journal of cutaneous medicine and surgery.

A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40 mg modified-release capsules versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea.

M. Schaller, M. Gooderham, L. Kemény, 2020, Journal of the American Academy of Dermatology.

Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.

A. Fleischer, Z. Draelos, M. Steinhoff, 2014, Journal of drugs in dermatology : JDD.

Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)

J. Werth, J. Schlessinger, L. Takiya, 2020, American Journal of Clinical Dermatology.

Diagnosis and Management of Atopic Dermatitis for Primary Care Providers

C. Lynde, B. O’Neill, P. Fleming, 2020, The Journal of the American Board of Family Medicine.

Review and Practical Guidance on Managing Fungal Infections in Patients With Psoriasis Receiving Anti-IL-17 Therapies

C. Lynde, R. Vender, J. Yeung, 2022, Journal of cutaneous medicine and surgery.

A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in Adults

M. Gooderham, K. Papp, Y. Poulin, 2018, Journal of cutaneous medicine and surgery.

Development and Validation of a Comprehensive Acne Severity Scale

W. Gulliver, Y. Poulin, Jerry Tan, 2007, Journal of cutaneous medicine and surgery.

The Personalised Acne Care Pathway—Recommendations to guide longitudinal management from the Personalising Acne: Consensus of Experts

B. Dréno, S. Beissert, Jerry Tan, 2021, JAAD international.

The Relationship Between Dermatologist- and Patient-Reported Acne Severity Measures and Treatment Recommendations

W. Gulliver, M. Frey, Y. Poulin, 2015, Journal of cutaneous medicine and surgery.

Development and Validation of a Scale for Acne Scar Severity (SCAR-S) of the Face and Trunk

W. Gulliver, Y. Poulin, Jerry Tan, 2010, Journal of cutaneous medicine and surgery.

Drug Interactions in Psoriasis: The Pros and Cons of Combining Topical Psoriasis Therapies

M. Lebwohl, C. Lynde, D. Sibbald, 2002 .

Immunohistochemical staining of macrophages in the skin lesions of leprosy: the role of antibody to mycobacteria in human serum and various polyclonal immune rabbit antisera

H. Yeger, L. From, Alexander Marks, 1985, The Histochemical Journal.

Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses

J. Ashkenas, Y. Poulin, C. Lynde, 2015, Journal of cutaneous medicine and surgery.

Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America

J. Sampalis, M. Gooderham, K. Papp, 2019, BMC Dermatology.

Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome

M. Gooderham, K. Papp, Y. Poulin, 2017, Allergy, Asthma & Clinical Immunology.

Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry

M. Gooderham, K. Papp, C. Lynde, 2022, Dermatology and Therapy.

Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study

L. Teixeira, T. Torres, P. Gisondi, 2021, American Journal of Clinical Dermatology.

Mexoryl: Broad-Spectrum Ultraviolet a Photoprotection

L. Guenther, C. Lynde, C. Zip, 2006 .

Treatments for primary delusional infestation: a systematic review (Preprint)

C. Lynde, P. Fleming, R. Gotesman, 2021 .

Proceeding report of the Symposium on Hidradenitis Suppurativa Advances (SHSA)

A. Kimball, Howard Hu, M. Gooderham, 2018, Experimental dermatology.

A Comprehensive Approach to the Recognition, Diagnosis, and Severity‐Based Treatment of Focal Hyperhidrosis: Recommendations of the Canadian Hyperhidrosis Advisory Committee

Kevin C. Smith, V. Bertucci, N. Solish, 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Moisturizers: what they are and a practical approach to product selection.

C. Lynde, J. Kraft, 2005, Skin therapy letter.

International Consensus Conference on Atopic Dermatitis II (ICCAD II * ): clinical update and current treatment strategies

J. Saurat, A. Giannetti, T. Luger, 2003, The British journal of dermatology.

Terbinafine therapy may be associated with the development of psoriasis de novo or its exacerbation: four case reports and a review of drug-induced psoriasis.

S. Knowles, N. Shear, C. Lynde, 1997, Journal of the American Academy of Dermatology.

Moisturizers for the treatment of inflammatory skin conditions.

C. Lynde, 2008, Journal of drugs in dermatology : JDD.

Twice-weekly topical calcipotriene / betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial).

M. Lebwohl, K. Papp, A. Wollenberg, 2020, Journal of the American Academy of Dermatology.

Screening patch tests in 4190 eczema patients 1972–81

J. Mitchell, C. Lynde, Johnny Mitchell, 1982, Contact dermatitis.

Patch testing with balsam of Peru and fragrance mix

J. Mitchell, C. Lynde, 1982, Contact dermatitis.

Itraconazole pulse therapy is effective in the treatment of tinea capitis in children: an open multicentre study

R. Summerbell, C. Lynde, A. Gupta, 1997, The British journal of dermatology.

Patch test results in 66 hairdressers 1973–81

J. Mitchell, C. Lynde, Johnny Mitchell, 1982, Contact dermatitis.

Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter canadian survey of 15,000 patients.

R. Summerbell, C. Lynde, Aditya K. Gupta, 2000, Journal of the American Academy of Dermatology.

Itraconazole and Terbinafine Treatment of Some Nondermatophyte Molds Causing Onychomycosis of the Toes and a Review of the Literature

R. Summerbell, C. Lynde, N. Konnikov, 2001, Journal of cutaneous medicine and surgery.

Therapeutic Options for the Treatment of Tinea Capitis Caused by Trichophyton Species: Griseofulvin Versus the New Oral Antifungal Agents, Terbinafine, Itraconazole, and Fluconazole

R. Summerbell, N. Morar, C. Lynde, 2001, Pediatric dermatology.

Onychomycosis in children: prevalence and treatment strategies.

B. Elewski, C. R. Daniel, N. Shear, 1997, Journal of the American Academy of Dermatology.

The efficacy and safety of terbinafine in children.

C. Lynde, Aditya K. Gupta, E. Cooper, 2003, Dermatologic clinics.

Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study

R. Summerbell, N. Morar, C. Lynde, 2000, The British journal of dermatology.

Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.

C. Lynde, N. Konnikov, Aditya K. Gupta, 2001, Journal of the American Academy of Dermatology.

Onychomycosis: predisposed populations and some predictors of suboptimal response to oral antifungal agents.

H. Degreef, R. Summerbell, C. Lynde, 1999, European journal of dermatology : EJD.

Itraconazole and Terbinafine Treatment of Some Nondermatophyte Molds Causing Onychomycosis of the Toes and a Review of the Literature

R. Summerbell, C. Lynde, N. Konnikov, 2001 .

Canadian Perspectives on Antifungal Treatment for Onychomycosis

Y. Poulin, C. Lynde, Aditya K. Gupta, 2006 .

Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison

B. Dréno, R. Bissonnette, Jerry Tan, 2018, American Journal of Clinical Dermatology.

P173 Prevalence of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada — A multicenter survey of 2001 patients

R. Summerbell, C. Lynde, Aditya K. Gupta, 1997 .

The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis

W. Gulliver, J. Pope, B. Haraoui, 2015, Annals of the rheumatic diseases.

A cohort study on a ceramide-containing cleanser and moisturizer used for atopic dermatitis.

C. Lynde, A. Andriessen, 2014, Cutis.

Off-Label Use of Topical Calcineurin Inhibitors in Dermatologic Disorders

Y. Poulin, L. Guenther, C. Lynde, 2019, Journal of cutaneous medicine and surgery.

Hormonal Approach to the Treatment of Acne

C. Lynde, 2005 .

Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis.

K. Papp, R. Bissonnette, Y. Poulin, 2010, Cutis.

Topical treatments for melasma and postinflammatory hyperpigmentation.

C. Lynde, C. Lynde, J. Kraft, 2006, Skin therapy letter.

Carbon Dioxide Laser-Treatment of Resistant Verrucae Vulgaris: Retrospective Analysis

C. Lynde, H. Haberman, K. Sloan, 1998, Journal of cutaneous medicine and surgery.

A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab

M. Wiseman, Y. Poulin, C. Lynde, 2021, Frontiers in Medicine.

Canadian Hand Dermatitis Management Guidelines

T. Agner, W. Gulliver, R. Bissonnette, 2010, Journal of cutaneous medicine and surgery.

Pharmacoeconomic Assessment of Ciclopirox Topical Solution, 8%, Oral Terbinafine, and Oral Itraconazole for Onychomycosis

C. Lynde, Aditya K. Gupta, K. Barber, 2006 .

Therapeutic Options for the Treatment of Darier’s Disease: A Comprehensive Review of the Literature

C. Lynde, M. Lam, P. Fleming, 2021, Journal of cutaneous medicine and surgery.

Nail disorders that mimic onychomycosis: what to consider.

C. Lynde, 2001, Cutis.

Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3b, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study.

B. Strober, M. Lebwohl, S. Tyring, 2020, Journal of the American Academy of Dermatology.

A Consensus on Acne Management Focused on Specific Patient Features

M. Wiseman, Jerry Tan, C. Lynde, 2014, Journal of cutaneous medicine and surgery.

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.

A. Gottlieb, A. Kimball, A. Armstrong, 2016, The New England journal of medicine.

Redefining treatment options in chronic hand eczema (CHE)

H. Maibach, P. Elsner, T. Luger, 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

Histiocytic lymphoma occurring in a patient with dermatitis herpetiformis.

C. Lynde, D. Jenkins, W. D. Stewart, 1983, Journal of the American Academy of Dermatology.

Sinecatechins and imiquimod as proactive sequential therapy of external genital and perianal warts in adults

S. Tatti, P. Calzavara-Pinton, C. Lynde, 2017, International journal of STD & AIDS.

A Randomized, Double-Blind, Multicenter, Parallel Group Study to Compare Relative Efficacies of the Topical Gels 3% Erythromycin/5% Benzoyl Peroxide and 0.025% Tretinoin/Erythromycin 4% in the Treatment of Moderate Acne Vulgaris of the Face

C. Lynde, Aditya K. Gupta, Smita Amin, 2003 .

C. Lynde, Aditya K. Gupta, Smita Amin, 2003, Journal of cutaneous medicine and surgery.

Comparison of the Treatment Guidelines for Actinic Keratosis: A Critical Appraisal and Review

C. Lynde, P. Fleming, R. Bobotsis, 2017, Journal of cutaneous medicine and surgery.

Pyogenic Granuloma: Pyogenic Again? Association between Pyogenic Granuloma and Bartonella

C. Lynde, J. Lee, 2001, Journal of cutaneous medicine and surgery.

Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris.

B. Elewski, E. Carter, Z. Draelos, 2007, Journal of the American Academy of Dermatology.

Truncal Acne: A Neglected Entity

C. Lynde, A. Alexis, E. Tanghetti, 2019, Journal of drugs in dermatology : JDD.

Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne.

M. Gooderham, Jerry Tan, D. Thiboutot, 2019, Journal of the American Academy of Dermatology.

Dysplastic Nevus

C. Lynde, C. Rosen, Sanjay Siddha, 2015, Journal of cutaneous medicine and surgery.

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis

K. Papp, Y. Poulin, N. Shear, 2005, Journal of cutaneous medicine and surgery.

Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanercept.

R. Bissonnette, Y. Poulin, L. Guenther, 2010, Journal of the American Academy of Dermatology.

Canadian Consensus on Skin Barrier Repair Therapy in Atopic Dermatitis

C. Lynde, I. Landells, R. Haber, 2012, Journal of cutaneous medicine and surgery.

Therapeutic Options for External Genital Warts

C. Lynde, R. Vender, M. Bourcier, 2013, Journal of cutaneous medicine and surgery.

One-Year, Multicenter, Open-Label, Single-Arm Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Moderate-to-Severe Plaque Psoriasis in a Canadian Population

C. Lynde, R. Vender, M. Poulin-Costello, 2013, Journal of cutaneous medicine and surgery.

Extended treatment with oral alitretinoin for patients with chronic hand eczema not fully responding to initial treatment

M. Sebastian, C. Lynde, F. Cambazard, 2012, Clinical and experimental dermatology.

Acitretin Use in Dermatology

L. Guenther, C. Lynde, R. Sibbald, 2017, Journal of cutaneous medicine and surgery.

Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond

P. Gisondi, M. Gooderham, R. Gniadecki, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting

G. Fabbrocini, T. Torres, L. Puig, 2022, Advances in Therapy.

Long-Term Effectiveness and Safety of Up to 48 Weeks’ Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne

B. Dréno, R. Bissonnette, Jerry Tan, 2019, American Journal of Clinical Dermatology.

Divergence of Demographic Factors Associated with Clinical Severity Compared with Quality of Life Impact in Acne

W. Gulliver, Y. Poulin, Jerry Tan, 2008, Journal of cutaneous medicine and surgery.

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial†

Kelly N. Taylor, Constance M. Brown, B. Elewski, 2019, The British journal of dermatology.

Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition

M. Wiseman, M. Gooderham, K. Papp, 2017, Journal of cutaneous medicine and surgery.

Clinical Features of External Genital Warts

C. Lynde, R. Vender, M. Bourcier, 2013, Journal of cutaneous medicine and surgery.

Identification of key research needs for topical therapy treatment of psoriasis – a consensus paper by the International Psoriasis Council

L. Iversen, R. Bissonnette, C. Lynde, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

HOW TO USE THE ABSTRACTS OF THE EUROPEAN CONGRESS ON PSORIASIS

S. Chimenti, A. Menter, L. Dubertret, 2004 .

Treating to Target(s) With Interleukin-17 Inhibitors

P. Rahman, W. Gulliver, K. Papp, 2019, Journal of cutaneous medicine and surgery.

Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis

C. Lynde, M. Ladda, P. Fleming, 2020, Journal of cutaneous medicine and surgery.

Upadacitinib plus topical corticosteroids in atopic dermatitis: week-52 AD Up study results.

J. Silverberg, T. Bieber, A. Costanzo, 2021, The Journal of allergy and clinical immunology.

Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry

M. Gooderham, K. Papp, C. Lynde, 2022, Dermatology and Therapy.

Practical Management of Patients with Atopic Dermatitis on Dupilumab

M. Gooderham, K. Papp, R. Bissonnette, 2021, Dermatology and Therapy.

Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO)

K. Schäkel, A. Costanzo, L. Puig, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis

M. Wiseman, M. Gooderham, L. Guenther, 2021, Frontiers in Medicine.

Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study

T. Torres, A. Balato, P. Gisondi, 2022, American Journal of Clinical Dermatology.

Review of Systemic Treatment Options for Adult Atopic Dermatitis

W. Gulliver, M. Gooderham, K. Papp, 2017, Journal of cutaneous medicine and surgery.

Tumors of ceruminous glands.

D. McLean, C. Lynde, W. Wood, 1984, Journal of the American Academy of Dermatology.

Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis

N. Sadick, K. Papp, S. Tyring, 2021, Journal of dermatological treatment (Print).

The Impact of Acne Treatment on Skin Bacterial Microbiota: A Systematic Review

C. Lynde, M. Lam, P. Fleming, 2021, Journal of cutaneous medicine and surgery.

B. Hales, Y. Poulin, N. Shear, 2009, Journal of cutaneous medicine and surgery.

ISA247: Quality of Life Results from a Phase II, Randomized, Placebo-Controlled Study

W. Gulliver, C. Lynde, R. Langley, 2008, Journal of cutaneous medicine and surgery.

The Use of Alefacept in the Treatment of Psoriasis

W. Gulliver, Y. Poulin, L. Guenther, 2004, Journal of cutaneous medicine and surgery.

Treatment of Atopic Dermatitis Using JAK Inhibitors: A Systematic Review

C. Lynde, Stefan T. Siedlikowski, V. Sandhu, 2019, EMJ Dermatology.

Management of moderate‐to‐severe plaque psoriasis with biologics: A treat‐to‐target position paper

M. Gooderham, C. Lynde, R. Vender, 2022, Dermatologic therapy.

Hair Removal Practices: A Literature Review.

C. Lynde, M. Shah, P. Fleming, 2021, Skin therapy letter.

Sleep Disturbances in Children With Atopic Dermatitis: A Scoping Review

C. Lynde, I. Mukovozov, P. Fleming, 2023, Journal of cutaneous medicine and surgery.

Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative

W. Gulliver, J. Pope, B. Haraoui, 2015, The Journal of Rheumatology.

Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice

D. Gladman, P. Rahman, J. Karsh, 2017, The Journal of Rheumatology.

Impacts of COVID-19 on Dermatologic Practice, Disease Presentation, and Immunomodulator Prescriptions

C. Lynde, P. Fleming, Maria Leis, 2020, Journal of cutaneous medicine and surgery.

Measuring h-index and scholarly productivity in academic dermatology in Canada

D. Sasseville, E. Rahme, M. Azar, 2022, Scientometrics.

Sir William Osler: Contributions to Dermatology From the Father of Medical Education

C. Lynde, V. Sandhu, 2018, Journal of Cutaneous Medicine and Surgery.

Prevalence and severity of facial and truncal acne in a referral cohort.

W. Gulliver, Y. Poulin, Jerry Tan, 2008, Journal of drugs in dermatology : JDD.

Directive clinique canadienne de consensus sur le virus du papillome humain

D. Provencher, A. Lalonde, J. Frappier, 2007 .

Omalizumab Retreatment and Step-Up in Patients with Chronic Spontaneous Urticaria: OPTIMA Trial.

William H. Yang, W. Gulliver, M. Gooderham, 2020, The journal of allergy and clinical immunology. In practice.

Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel

J. Lambert, S. Hotte, M. Gooderham, 2023, Dermatology and Therapy.

Pathway to Dry Skin Prevention and Treatment

L. Guenther, C. Lynde, S. Skotnicki, 2012, Journal of cutaneous medicine and surgery.

Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study

J. Silverberg, A. Wollenberg, D. Murrell, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Perspectives and knowledge of acne vulgaris among young adolescents

C. Lynde, P. Fleming, Chaocheng Liu, 2022, Pediatric dermatology.

Psoriasis Prevalence and Severity by Expert Elicitation

M. Gooderham, K. Papp, R. Gniadecki, 2021, Dermatology and Therapy.

Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial

J. Shapiro, D. Mitra, B. King, 2023, The Lancet.

‘Rex noster insanit’

C. Lynde, C. Lynde, J. Kraft, 2018, Journal of cutaneous medicine and surgery.

Healthcare Resource Utilisation Among Chronic Spontaneous/Idiopathic Urticaria Patients- Findings From The First International Burden of Illness Study (Assure-Csu).

A. Knulst, C. Lynde, A. Halliday, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Advances in Understanding and Managing Chronic Urticaria

C. Lynde, Y. Moolani, G. Sussman, 2016, F1000Research.

Advances in Understanding and Managing Chronic Urticaria

C. Lynde, Y. Moolani, G. Sussman, 2016, F1000Research.

Common Atopic Dermatitis Rating Scales: A Practical Approach and Brief Review

C. Lynde, P. Fleming, Y. Yang, 2020, Journal of cutaneous medicine and surgery.

A SUPPLEMENT TO JDD CliniCal insights about the Role of skin ph in inflammatoRy DeRmatologiCal ConDitions

Jerry Tan, C. Lynde, 2019 .

Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials

J. Silverberg, C. Patruno, K. Abuabara, 2023, American Journal of Clinical Dermatology.

Expert consensus on the systemic treatment of atopic dermatitis in special populations

M. Gooderham, K. Papp, C. Lynde, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.

Work Productivity and Activity Impairment Among Chronic Spontaneous/Idiopathic Urticaria Patients: ResultsFrom The First International Burden of Illness Study (Assure-Csu).

A. Knulst, C. Lynde, A. Halliday, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.

S. Forman, C. Lynde, L. Kircik, 2023, JAMA dermatology.

A Brief History of Psoriasis Management in Canada

C. Lynde, Khalad Maliyar, P. Fleming, 2020, Journal of cutaneous medicine and surgery.

Topical treatment of psoriasis: questionnaire results on topical therapy accessibility and influence of body surface area on usage

L. Iversen, C. Lynde, J.J. Wu, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009

W. Gulliver, M. Wiseman, M. Gooderham, 2016 .

Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting

M. Gooderham, K. Papp, C. Lynde, 2021, The British journal of dermatology.

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document

M. Wiseman, M. Gooderham, K. Papp, 2018, Journal of Cutaneous Medicine and Surgery.

A treatment for severe nodular acne: a randomized investigator‐blinded, controlled, noninferiority trial comparing fixed‐dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin

M. Gooderham, Jerry Tan, C. Lynde, 2014, The British journal of dermatology.

Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safety.

C. Lynde, N. Kerrouche, T. Dirschka, 2010, Journal of drugs in dermatology : JDD.

Effect of Quality of Life Impact and Clinical Severity on Adherence to Topical Acne Treatment

W. Gulliver, Y. Poulin, Jerry Tan, 2009, Journal of cutaneous medicine and surgery.

Cohort study on the treatment with dapsone 5% gel of mild to moderate inflammatory acne of the face in women.

C. Lynde, A. Andriessen, 2014, Skinmed.

Non-melanoma Skin Cancer in Canada Chapter 1: Introduction to the Guidelines

J. Ashkenas, L. Guenther, C. Lynde, 2015, Journal of cutaneous medicine and surgery.

Economic burden of moderate to severe plaque psoriasis in Canada

A. Levy, C. Lynde, A. Davie, 2012, International Journal of Dermatology.

OBSERVE-5: Comparison of Etanercept-Treated Psoriasis Patients From Canada and the United States

K. Papp, Y. Poulin, C. Lynde, 2018, Journal of cutaneous medicine and surgery.

Work Productivity and Healthcare Resource Utilization Outcomes for Patients on Etanercept for Moderate-to-Severe Plaque Psoriasis

C. Lynde, D. Chau, R. Vender, 2012, Applied Health Economics and Health Policy.

Improvements in patient‐reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE

R. Bissonnette, Y. Poulin, C. Lynde, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Efalizumab: Integrating a new biologic agent into the long-term management of moderate to severe plaque psoriasis

C. Lynde, 2005, Journal of cutaneous medicine and surgery.

Comparative study of the efficacy and safety of loratadine syrup and terfenadine suspension in the treatment of chronic allergic skin diseases in a pediatric population.

L. Degroot, C. Lynde, B. Guillot, 1993, Arzneimittel-Forschung.

The Skin Microbiome in Atopic Dermatitis and Its Relationship to Emollients

M. Wiseman, V. Bertucci, C. Lynde, 2016, Journal of cutaneous medicine and surgery.

Practical and Relevant Guidelines for the Management of Psoriasis: An Inference-Based Methodology

M. Gooderham, K. Papp, R. Gniadecki, 2021, Dermatology and Therapy.

Chronic Spontaneous Urticaria (CSU)

C. Lynde, Loretta Cheung, 2016, Journal of cutaneous medicine and surgery.

Patch test results with a shoewear screening tray in 119 patients, 1977–80

C. Lynde, J. Mitchell, L. Warshawsri, 1982, Contact dermatitis.

Prevalence of onychomycosis in patients visiting dermatologists' offices in Ontario, Canada — A multicenter survey of 15,000 patients

R. Summerbell, C. Lynde, Aditya K. Gupta, 1998 .

P174 A higher prevalence of onychomycosis in abnormal appearing nails in psoriatics compared to non-psoriatics: A multicenter study

C. Lynde, Aditya K. Gupta, H. Jain, 1997 .

Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspective.

M. Wiseman, M. Gooderham, C. Lynde, 2023, Journal of the American Academy of Dermatology.

Increased expression of IL‐17A and limited involvement of IL‐23 in patients with palmo‐plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial

R. Bissonnette, C. Lynde, R. Langley, 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

Certolizumab Pegol Use in the Treatment of Moderate-to-Severe Psoriasis: Real-World Data From Two Canadian Centers

C. Lynde, R. Vender, 2022, Journal of cutaneous medicine and surgery.

Novel agents for intractable itch.

C. Lynde, C. Lynde, J. Kraft, 2008, Skin therapy letter.

Treatments for Primary Delusional Infestation: Systematic Review

C. Lynde, P. Fleming, R. Gotesman, 2021, JMIR dermatology.

W. Gulliver, B. Haraoui, C. Roubille, 2015, The Journal of Rheumatology.

THU0412 Cardiovascular Outcomes in Patients with Rheumatoid Arthritis, Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-Analyses

W. Gulliver, J. Pope, B. Haraoui, 2014 .

The AWARE Study: Methodology and Baseline Characteristics

H. Lui, W. Gulliver, K. Papp, 2009, Journal of Cutaneous Medicine and Surgery.

Canadian Clinical Practice Guidelines for Rosacea

C. Cochrane, A. Baibergenova, Y. Poulin, 2016, Journal of cutaneous medicine and surgery.

Effect of upadacitinib on atopic hand eczema in patients with moderate‐to‐severe atopic dermatitis: Results from two randomized phase 3 trials

E. Simpson, C. Lynde, P. Lio, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.

The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity

M. Wiseman, M. Gooderham, L. Guenther, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis

M. Wiseman, M. Gooderham, K. Papp, 2018, Journal of cutaneous medicine and surgery.

Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition

M. Wiseman, M. Gooderham, K. Papp, 2017, Journal of cutaneous medicine and surgery.

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.

A. Gottlieb, A. Kimball, A. Armstrong, 2016, The New England journal of medicine.

Acitretin revisited.

C. Lynde, C. Lynde, J. Kraft, 2011, Skin therapy letter.

Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne.

M. Gooderham, Jerry Tan, D. Thiboutot, 2019, Journal of the American Academy of Dermatology.

PSS17 IMPACT OF ADALIMUMAB ON QUALITY OF LIFE AND DEPRESSION IN PSORIASIS PATIENTS: RESULTS FROM PRIDE

N. Bansback, A. Anis, D. Guh, 2010 .

TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled Study.

J. Tardif, M. Guertin, R. Bissonnette, 2017, The Journal of investigative dermatology.

Canadian Guidelines for the Management of Plaque Psoriasis: Overview

J. Ashkenas, W. Gulliver, K. Papp, 2011, Journal of cutaneous medicine and surgery.

Patient impact and economic burden of mild-to-moderate atopic dermatitis

R. Gerber, J. Cappelleri, C. Lynde, 2018, Current medical research and opinion.

M. Lahfa, T. Ruzicka, R. Bissonnette, 2008, The British journal of dermatology.

Enhanced Effectiveness of Adalimumab Compared to Topical/Traditional Systemic Agents in the Treatment of Moderate to Severe Plaque Psoriasis: Results from a Canadian Observational Epidemiologic Study (COMPLETE-PS)

C. Lynde, R. Vender, K. Ohson, 2022, Dermatology and Therapy.

Managing External Genital Warts: Practical Aspects of Treatment and Prevention

C. Lynde, R. Vender, M. Bourcier, 2013, Journal of cutaneous medicine and surgery.